Media

BIO Investor Forum to be held October 7-8, 2014 in San Francisco, California
Survey responses will help inform Prescription Drug User Fee Act VI negotiations

Press Releases

Jul 29 2013
Washington, D.C. (July 22, 2013)– The Biotechnology Industry Organization (BIO) today released a statement in support of the FDA Safety Over...
Jul 29 2013
GMO Answersresponds to the toughest questions about GMOs, puts previously hard-to-find health and safety information in one place for the first time...
Jul 26 2013
Washington, D.C. (July 26, 2013) – The Renewable Fuels Standard (RFS) must be maintained in order to spur alternative energy production and mitigate...
Jul 25 2013
WASHINGTON, D.C. (July 24, 2013) – In the latest edition of the Food and Drug Policy Forum, an article by Food & Water Watch asserts that FDA is...
Jul 18 2013
WASHINGTON, DC (July 18, 2013) – The Biotechnology Industry Organization (BIO) today announced changes designed to strengthen and improve the BIO...
Jul 10 2013
WASHINGTON, D.C. (July 10, 2013) – Because of the environmental, economical and societal benefits they provide, genetically engineered (GE) varieties...
Jul 10 2013
Washington DC, July 10, 2013– Today, the Biotechnology Industry Organization (BIO) thanks Rep. Michael Fitzpatrick (R-PA) for introducing H.R. 2629,...
Jul 10 2013
Washington, DC (July 10, 2013, 11:00am EST)– Today, the House Financial Services' Subcommittee on Capital Markets and Government Sponsored...
Jul 2 2013
The Biotechnology Industry Organization (BIO) today thanked Agriculture Secretary Tom Vilsack for reopening the BioPreferred Bioproduct Certification and...


Biotechnology News

September 1, 2014

RYDALMERE, Australia--(BUSINESS WIRE)--Welch Allyn, a leading medical diagnostic device company that delivers pragmatic innovation at the point of care, today introduced...

September 1, 2014

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ:EXEL) today announced top-line results from the final analysis of COMET-1, the phase 3 pivotal trial...

September 1, 2014

LONDON & BOSTON & TOKYO--(BUSINESS WIRE)--Evaluate announced the appointment of Alex Karle to the role of Chief Executive Officer. Dr Jonathan de Pass, founder and...

September 1, 2014

INGELHEIM, Germany--(BUSINESS WIRE)--For Non-US/Non-UK/Non-Canadian Media Five years on from the first breakthrough presentation of the pivotal RE-LY® clinical trial of...

September 1, 2014

DUBLIN--(BUSINESS WIRE)--Research and Markets (...